Objective: To establish whether sickle cell disease (SCD) affects cognitive functioning in children with no evidence of cerebral infarction.
cerebral vascular injuries have cognitive effects related to SCD, however, is not well established. In a recent report from the Cooperative Study of Sickle Cell Disease (CSSCD) serial cognitive testing suggested children with SCD and normal brain magnetic resonance imaging (MRI) exams showed declines in verbal IQ scores over the course of a 5-year period (Wang et al., 2001 ). In addition, there were age-related declines on a test of psychomotor speed and focused attention (coding subtest of the Wechsler scales) and mathematics achievement. Though highly suggestive, this report is limited by the absence of a healthy comparison group for the CSSCD data.
The primary purpose of this report is to further evaluate the effects of SCD on cognitive functioning through the review and analysis of published studies.
Our goal for this report is to evaluate five unresolved issues regarding the effects of sickle cell disease on cognitive functioning. Although a number of reports have examined cognitive functioning in SCD, they have reached different conclusions about cognitive effects related to the disease. It is unlikely that any two groups have identical population means, so the discrepancy across studies is probably best framed in terms of a related question: How large or meaningful are any effects of SCD on cognitive functioning?
An important difference among studies has been the use of IQ as the outcome variable, as opposed to also examining specific areas of cognitive functioning. IQ scores have been the most frequent method for evaluating cognitive functioning, but there are some potential pitfalls with using IQ as the sole outcome measure. First, most IQ tests measure only a subset of abilities that may be relevant to cognitive functioning. For example, the commonly used Wechsler scales at best measure three or four factors, and there is minimal inclusion of tests tapping into important areas of cognition such as memory and executive skills (Wechsler, 1991) . Some cognitive models have at least eight cognitive factors that may provide unique information (e.g., Horn & Noll, 1997) . Second, if there is a deficit in a specific area of cognitive ability, IQ scores may underestimate its size by essentially averaging scores on unaffected and affected skill areas. It would be useful to know how to balance between the parsimony of IQ as a single cognitive outcome measure and the potential increased sensitivity of multiple measures. Depending on the manner in which the disease affects cognition, either choice could increase the likelihood of detecting a true effect on cognition. Thus, the most appropriate choice of the best outcome measures to evaluate cognition in children with SCD but no cerebral infarction has not been established.
A second methodological issue evident in prior reports is the use of different comparison groups. Predominantly, researchers have used either siblings of the participants with SCD (typically mixed groups including both those with normal hemoglobin and sickle cell trait) or demographically matched peers. In the second case, there has usually been matching for at least age, race/ethnicity, and some index of socioeconomic status (SES). It has been suggested that the best comparison groups are siblings (White & DeBaun, 1998 ) because sibling comparison groups have greater similarity in terms of factors such as family environment, but they have other potential limita-
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Schatz, Finke, Kellett, and Kramer tions. For example, not every child with SCD has a sibling within the required age range of the study or any sibling at all. Thus, when using siblings, there are typically fewer controls than cases. In addition, siblings are typically not the same age as the child affected with SCD, which can pose limits for precise matching of cases and controls according to age. Thus, there is no widely accepted "gold standard" for a control group. The degree to which the choice of comparison group has affected the outcomes of prior studies has not been evaluated empirically, and such information could be useful for interpreting prior research and guiding the design of future studies. Another methodological issue has been the exclusionary criteria for stroke or cerebral vascular injury. In many reports, neurologic status was determined solely from medical history information without supporting evidence from neuroimaging. Recently there has been increased awareness of the prevalence and cognitive effects of "silent cerebral infarcts." Silent cerebral infarcts are vascular injuries evident on magnetic resonance imaging (MRI) exams in children without a history of a neurologic event. Silent cerebral infarcts occur in approximately 15% of children with hemoglobin type SS (HbSS) by age 12 and result in cognitive deficits (Armstrong et al., 1996; Bernaudin et al., 2000; Brown et al., 2000; Craft et al., 1993; DeBaun et al., 1998; Kugler et al., 1993; Wang et al., 2001; Watkins et al., 1998) . Several reports have suggested that the failure to exclude children with silent infarcts from studies is the primary factor responsible for data indicating cognitive deficits in children with SCD who do not have a history of overt stroke (Craft et al., 1993; White & DeBaun, 1998) . The impact of using MRI versus neurologic history as a criterion has not been evaluated empirically. More important, the issue of whether children who are free from silent cerebral infarcts show cognitive deficits is an unresolved issue.
Finally, there has been mixed evidence as to whether any cognitive effects of sickle cell disease become worse with age. Several reports have indicated that older children with SCD show worse cognitive performance than younger children with SCD (Brown et al., 1993; Fowler et al., 1988; Wang et al., 2001) , whereas other reports have specifically examined for age effects but have not found this pattern (Goonan et al., 1994; Noll et al., 2001; Steen, Xiong, Mulhern, Langston, & Wang, 1999; Swift et al., 1989; Wasserman, Wilimas, Fairclough, Mulhern, & Wang, 1991) . Understanding whether any cognitive effects of SCD progress with age is important for identifying the responsible mechanisms and planning appropriate monitoring and interventions.
Method

Identification of Prior Studies
Literature searches were conducted using MEDLINE (years 1975-2001) , PsycInfo (years 1887 PsycInfo (years -2001 , and Dissertation Abstracts (years 1861-2001) databases using the key words "sickle cell" paired with each of the following terms: "cognitive," "neuropsychologic," "IQ ," and "intelligence." Publications that included cognitive testing of a group of children with SCD but no history of stroke and a comparison group without SCD were identified. The references of each article identified were also reviewed to seek additional articles that might meet the criteria for inclusion. The following data were extracted from each study: (1) the inclusion and exclusionary criteria for each study group, (2) the number of participants and ages of each group, (3) the sickle cell disease subtypes included in the study, (4) the type of cognitive measures used and any conceptual or factorial grouping & Okuyiga, 1996) , and the sample size did not allow for a meaningful test of potential differences between subtypes.
Previously Unreported Data
Three additional sources of data were used for this research. Two previous studies of cognitive functioning in children with SCD had reported data on subtests of IQ measures but did not report the data in terms of IQ scores. In both of these two data sets, estimated IQ scores based on short forms of the intelligence test measures were computed (Sattler, 1988) . Controls from the WISC-PI normative sample.
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The first was a report by Craft et al. (1993) that used subtests of the Wechsler Intelligence Scale, Revised (WISC-R; Wechsler, 1974) . The second source was a data set that included subtests of the Differential Abilities Scale (Elliot, 1984) , administered to 25 children with sickle cell disease but no cerebral infarcts on MRI (Schatz, 1997) and 17 sibling controls without SCD (Schatz et al., 1999) . The SCD and sibling groups were closely matched in age (12.2 vs. 12.1 years, respectively), grade (5.8 vs. 5.6, respectively), and SES based on the Hollingshead Two-Factor Index of Social Position (Hollingshead scores of 61.0 vs. 57.6, respectively, or "upper lower class" according to the descriptive labels for the measure). The third source was data from the standardization sample of the Wechsler Intelligence Test for Children-Process Instrument (WISC-PI; Kaplan, Fein, Kramer, Delis, & Moris, 1999) . The WISC-PI standardization sample included a national sample of children that had concurrently been administered the WISC-PI and a seven-subtest version of the WISC-III. This allowed for computing a prorated Verbal IQ (Information, Vocabulary, Arithmetic subtests), Performance IQ (Picture Completion, Coding, Block Design subtests), and Full Scale IQ. The Digit Span subtest was also administered to this sample. Data on race/ethnicity, age, and maternal education were available that allowed for extracting a demographically matched sample to children participating in the CSSCD (see Table II ; Armstrong et al., 1996; Wang et al., 2001 ). For the WISC-III PI control group, means (standard deviations) were a Verbal IQ of 91.1 (15.6), Performance IQ of 93.1 (19.7), and Full Scale IQ of 91.8 (16.5). The control group also showed a Digit Span scaled score of 10.0 (3.7) and a Coding scaled score of 9.5 (4.2).
Results
IQ Scores Across All Studies
Mean IQ scores were weighted according to the number of participants for each study. Cohen's d was computed as a measure of effect size (Cohen, 1988) . As shown in Table III , the overall difference in scores between children with SCD and comparison children was 4.3 standard score points with an effect size of d = -0.313, t(1075) = -5.02, p < .01. These data are based on 631 children with SCD and 446 comparison children. According to conventional definitions, this is a small effect size (r = .15; Cohen, 1988 
IQ Versus More Specific Cognitive Areas
Among those studies examining differences in both IQ and specific cognitive domains, 7 of the 14 studies (50%) found differences in IQ , and 10 of 14 studies (71%) found differences in specific cognitive areas as measured by either specific tests or domain scores (see Table IV ). Among the 10 studies reporting specific areas of cognitive deficits, 8 of the 10 showed deficits on tests or factors that could be broadly defined as measures of attention and executive skills, such as the Coding and Digit Span subtests of the Wechsler scales, or the Matching Familiar Figures test. Four of ten studies found differences on measures of verbal or language functions, and 3 of 10 found differences on measures of memory functions. Outcomes among the studies that examined both IQ and specific areas of cognitive ability appeared to be related to sample size. Studies reporting null results had a mean of 23.5 children with SCD (SD = 8.1) and 18.5 controls (SD = 7.3), whereas those with statistical differences had a mean of 51.7 children with SCD (SD = 36.2) and 33.6 controls (SD = 20.6). Thus, the studies with null results had significantly fewer participants (t[12] = -2.47, p < .05).
For each study that looked at specific cognitive areas, power calculations were made to determine Maternal education for the SCD group was based on the data reported for the CSSCD baseline assessment (Armstrong et al., 1996) .
the effect size the study was capable of detecting (Cohen, 1988) . Power was set at .80 and alpha was set at .05 for the calculations. For the studies that found null results, the mean effect size they were capable of detecting was r = .43 (SD = .05). For the studies that found significant differences, the mean effect size they were capable of detecting was r = .34 (SD = .10). From these calculations, it is estimated that the effect size of the specific cognitive deficits likely is of a medium size (r value between .34 and .43). 
Choice of Comparison Group
For studies using a demographically matched control group, the mean (SD) IQ score was 90.6 (14.0), compared with 85.3 (13.1) for children with SCD. This is a raw score difference of 5.3 points with an effect size of d = -0.396, t(452) = -4.19, p < .01. For studies using a sibling comparison group, the mean IQ score was 90.7 (13.0), compared with 87.2 (14.2) for children with SCD. This is a raw score difference of 3.5 points with an effect size of d = -0.253, t(621) = -3.08, p < .01. The difference in effect size between studies using demographically matched controls versus those using siblings controls was not statistically significant (z = 1.15, ns).
Exclusion of Silent Infarct Cases
For studies using neurologic history alone to exclude for cerebral infarction, the mean IQ score was 90.2 (12.7) for controls and 87.1 (13.1) for children with SCD. This is a raw score difference of 3.1 points with an effect size of d = -.239, t(570) = -2.81, p < .01. For studies using MRI to exclude for cerebral infarction, the mean IQ score was 91.2 (14.3), compared with 85.6 (14.4) for children with SCD. This is a raw score difference of 5.6 points with an effect size of d = -0.388, t(503) = -4.24, p < .01. The size of the discrepancy did not differ according to use of MRI (z = 1.18, ns). The interaction between choice of control group and use of MRI was also examined. The most methodologically rigorous method could be considered the use of sibling controls with MRI used to exclude silent infarct cases (White & DeBaun, 1998 
IQ Discrepancy by Age of Sample
The magnitude of IQ difference was evaluated according to the mean age of the sample (see Table I ). Studies were grouped according to those with mean ages of 9 to 10 years (n = 5), 10 to 11 years (n = 5), or 11 to 13 years (n = 5). This grouping indicated that the difference in raw IQ points and effect sizes increased as as the samples aged (see Table V ). For the studies with a mean age of 9 to 10 years, there was no significant IQ difference between children with SCD and comparison children (t[264] = 0.50, ns). There was a significant IQ difference for samples with a mean age of 10 to 11 years (t[303] = -2.90, p < .01) and 11 to 13 years (t[384] = -5.44, p < .01). A comparison of the effect sizes for at each age grouping showed that the effect size for the 9-to 10-year-old samples was smaller than for the 11-to 13-year-old samples (z = -2.93, p < .01). There was a trend toward a smaller difference between the 9-to 10-year-old samples than the 10-to 11-year-old samples (z = -1.60, p < .06). The effect sizes for 10-to 11-year-old samples did not differ from the 11-to 13-year-old samples (z = -1.30, ns).
Discussion
The introduction outlined five questions that could be addressed by this meta-analysis. The following discussion clarifies how the data inform these ques- Grand means for IQ data were weighted according to the n for the study. *Effect sizes differ, p < .05.
tions and provides suggestions for research and clinical management of SCD.
Effect Size for Cognitive Functioning and Choice of Outcome Measures
This meta-analysis indicates at least a small decrement in cognitive functioning in children with SCD who are free from cerebral infarcts. The analyses indicated approximately a 4-to 5-point decrement on IQ measures compared with control groups. Including only studies with more stringent methods (e.g., use of MRI) did not diminish the size of this IQ difference. The effect size for IQ scores is small but within the range of other disorders with known neuropsychological effects. The general cognitive deficit in SCD is smaller than the IQ changes reported with acute lymphoblastic leukemia treated with cranial radiation therapy (10 points on average; Cousens, Waters, Said, & Stevens, 1988) or brain tumors in children treated with radiation therapy (12-14 points on average; Mulhern, Hancock, Fairclough, & Kun, 1992) . The general cognitive decrement with SCD, however, is comparable to those reported for patients with early and continuously treated phenylketonuria (7 points on average; Burgard, 2000) and long-term survivors of bacterial meningitis (6 points on average; Grimwood et al., 1995) . In addition, the IQ discrepancy between children with SCD that have silent cerebral infarcts compared with those that have normal MRI is approximately 4-7 points (Armstrong et al., 1996; Bernaudin et al., 2000; Wang et al., 2001 ). The primary finding of a small decrement on IQ measures may also underestimate the meaningfulness of the cognitive effect. Measures of specific cognitive abilities appear to be more sensitive to the cognitive effects than IQ measures and likely represent a medium effect on cognition. It is possible, therefore, that a specific cognitive domain shows a larger effect that is attenuated when global measures are computed. There was some variability in the outcomes for tests of specific cognitive abilities, but overall the general domain of attention and executive functions seems most notably affected. These data indicate the importance of assessing specific cognitive domains when evaluating children with SCD. Outcome studies examining cognitive functioning in this population should also include measures of specific cognitive domains rather than relying solely on IQ scores.
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Choice of Control Group
The use of siblings as a comparison group has been described as the preferable control group for studying the cognitive effects of SCD (White & DeBaun, 1998) . The data from this study indicate that, overall, studies using demographically matched peers as a control group showed approximately a 2-point greater IQ discrepancy than studies that used a sibling control group. This difference was a very small effect and did not reach statistical significance with a large number of cases and controls. There is no evidence from this empirical review that the choice of control groups poses a meaningful bias in outcomes for general cognitive functioning. In planning future studies, researchers need to attend closely to the qualities of their particular sample of comparison children, but either siblings or nonsibling peers are appropriate choices. Researchers may consider which matching variables are most important for their research question in choosing between these options. For example, if developmental processes were judged as a key factor for a study, more precise age matches could be achieved with a nonsibling case-control design; if family environment or genetics were judged a more critical factor, a sibling control group might be more appropriate.
There is some indication that selection of the SCD cases is a more important factor for study designs. The discrepancy between cases and controls on IQ measures was strongly related to the IQ scores for the SCD cases, but not for the controls. This may indicate a sampling bias in some of these studies. For example, researchers may have unknowingly overrecruited children with SCD who have particularly poor cognitive functioning. Recruiting a representative sample of children with SCD is likely a much more robust factor for study outcomes than the choice of siblings versus demographically matched peers.
Ruling Out Cerebral Infarction
The use of neurologic history alone to exclude children with cerebral infarction has been a common approach in the study of cognition in SCD. These analyses indicate that the use of MRI to exclude cases with silent infarcts has no significant effect on the size of group IQ differences. For the age range of children included in most studies, one would expect approximately 15% of children with normal neurologic history to have silent cerebral infarction and that these children would show approximately a 4-7-point decline on IQ measures (Armstrong et al., 1996; Bernaudin et al., 2000) . Applying these population estimates to a group of children with SCD, one would expect the inclusion of silent infarct cases to decrease the SCD group IQ scores by approximately 1 standard score point at most. Thus, the use of neurologic history rather than MRI in prior studies likely had a minimal impact on the overall group difference in IQ scores.
The greater source of error associated with failing to exclude silent cerebral infarction may be in understanding the cause of cognitive deficits in children free from cerebral infarcts. It is possible that the inclusion of silent infarct cases obscures potentially meaningful relationships within the group of children with SCD. For example, in two studies using MRI to exclude cases with silent infarcts, a moderate to large relationship was found between hematocrit and cognitive functioning (Bernaudin et al., 2000; Steen et al., 1999) . In studies using neurologic history alone, the relationship between these variables has been smaller in size or not statistically significant (Brown et al., 1993; Fowler et al., 1988; Swift et al., 1989) .
Age-Related Changes in Cognitive Functioning
The analysis of age effects in this study is consistent with data from the recent CSSCD report suggesting declines in cognitive functioning with increasing age (Wang et al., 2001) . Although this meta-analysis has a larger sample size than prior reports, it examined age effects in a cross-sectional manner. This approach is subject to many potential confounds such as cohort effects across studies or sampling biases of studies. The averaging of data across multiple studies for each age group may not eliminate these confounds. Thus, this finding of age effects should be viewed as only suggestive. Prospective study of children with SCD and a control group is needed to clearly establish the age effects found in this and other reports. In addition, the precise relationship between age and cognitive decrements is not clear. Most study samples have been predominantly composed of children between approximately 7 and 12 years of age. Expanding the age range to understand cognitive functioning in preschool children and adolescents is needed. Notably, only one study identified focused on adolescents, and no studies examined cognitive functioning in preschool children or adults.
The indication of possible age effects over middle childhood suggests this may be an important period for routine monitoring of cognitive functioning. Baseline assessments of cognitive functioning are typically not conducted in routine clinical care of sickle cell disease. This practice may limit the detection of subtle cognitive effects. If a child with SCD shows declines in academic performance in school, a baseline assessment conducted at a younger age would allow for a more informed judgment about possible cognitive declines.
Conclusions
There are at least two remaining questions related to the data in this report. First, it is not yet clear what is causing these cognitive effects in SCD. A number of potential physiological effects on brain function have been described (Brown et al., 1993) . These potential mechanisms include an accumulation of microinfarcts that may not be visible on standard imaging exams, chronic brain hypoxia related to severe anemia, acute hypoxia related to physical complications such as acute chest syndrome, and nutritional deficiencies related to high metabolic demands (Brown et al., 1993) . Among these direct effects, some data have supported the presence of hypoxic changes in brain tissue for children with SCD (Steen et al., 1998 (Steen et al., , 1999 .
As an alternative to more direct effects of SCD on brain functioning, indirect effects related to social or environmental disadvantages (e.g., decreased learning opportunities, increased physical limitations from chronic illness) have been cited as potential causes (e.g., Brown et al., 1993; Wang et al., 2001 ). Indirect effects related to social and environmental disadvantages may also be relevant for understanding a broader range of impediments to cognitive development in this population. For example, the demographically matched comparison groups in this report had a grand mean IQ score of 90.7, which falls below the population mean. Both children with SCD and the comparison group likely share a higher number of environmental risk factors than the general population. Developmental outcomes for children with biological risk factors (e.g., preterm birth, brain insults) have been shown to be more dependent on the quality of the social environment than for children without these biological factors (Greenberg & Crnic, 1988; Landry, Smith, Miller-Loncar, & Swank, 1997; Smith et al., 1996; Taylor et al., 2002) . Thus, both the social context of a child with SCD and the interaction of that context with the disease may be critical to developmental outcomes.
More research studies are needed using methods that allow for strong causal inferences. Most studies of cognition in sickle cell disease have been crosssectional designs. Greater use of longitudinal and experimental designs is needed. Research that manipulates potential causal factors is needed to identify effective preventative and remedial interventions. For example, interventions that reduce anemia levels (e.g., effects of blood transfusion or hydroxyurea therapy) could be useful manipulations to better show how anemia or other physical factors relate to cognitive outcomes. The study of indirect effects could be enhanced by proposing more precise models of the causal route and using path modeling rather than the more exploratory designs that have been used to date. In addition, there have been few attempts to simultaneously evaluate the relative contribution of different causes. Variables such as hema-tocrit levels and frequency of illness may be related, which creates confounds if these variables are examined in isolation.
The second remaining issue is the functional meaning of these cognitive effects. We do not know if the cognitive effects are significant contributors to problems in school functioning, vocational success, or other aspects of quality of life. It is difficult to determine the need for intervention without such data. Studying the effects of hydroxyurea therapy on cognitive functioning has been proposed as one potential treatment for reducing cognitive effects (Bernaudin et al., 2000) . Although this treatment warrants investigation, determining the risk-tobenefit ratio for any intervention targeting cognitive functioning should examine both cognitive test scores and functional outcome measures. February 3, 2001; revisions received February 11, 2002; accepted March 29, 2002 
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